Activist 13D/13G Filings - VYNE Therapeutics Inc. (VYNE)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-11-14
3:34 pm
Sale
13GVYNE THERAPEUTICS INC PAR$
VYNE
Soleus Capital Master Fund L.P.0
0.000%
-703,868decrease
(Position Closed)
View
2024-02-14
4:57 pm
Sale
13GVYNE THERAPEUTICS INC PAR$
VYNE
CITADEL ADVISORS LLC1,181,144
8.500%
-23decrease
(-0.00%)
View
2024-02-02
09:42 am
Sale
13GVYNE THERAPEUTICS INC PAR$
VYNE
Soleus Capital Master Fund L.P.703,868
5.000%
-187,000decrease
(-20.99%)
View
2023-11-13
4:41 pm
Purchase
13GVYNE THERAPEUTICS INC PAR$
VYNE
CITADEL ADVISORS LLC1,181,167
8.500%
1,181,167increase
(New Position)
View
2023-11-13
4:10 pm
Purchase
13GVYNE THERAPEUTICS INC PAR$
VYNE
EVENTIDE ASSET MANAGEMENT LLC1,394,336
9.990%
1,394,336increase
(New Position)
View
2023-11-13
4:03 pm
Purchase
13GVYNE THERAPEUTICS INC PAR$
VYNE
Cormorant Asset Management LP1,394,336
9.990%
1,394,336increase
(New Position)
View
2023-11-13
08:24 am
Purchase
13DVYNE THERAPEUTICS INC PAR$
VYNE
AI Biotechnology LLC3,201,980
19.990%
3,201,980increase
(New Position)
View
2023-11-02
4:15 pm
Purchase
13GVYNE THERAPEUTICS INC PAR$
VYNE
Soleus Capital Master Fund L.P.890,868
6.400%
890,868increase
(New Position)
View
2022-02-14
7:33 pm
Sale
13GVYNE THERAPEUTICS INC PAR$
VYNE
PERCEPTIVE ADVISORS LLC2,425,604
4.500%
-2,562,283decrease
(-51.37%)
View
2021-08-25
5:04 pm
Purchase
13GVYNE THERAPEUTICS INC PAR$
VYNE
PERCEPTIVE ADVISORS LLC4,987,887
9.600%
4,987,887increase
(New Position)
View
2021-07-09
6:05 pm
Purchase
13GVYNE THERAPEUTICS INC PAR$
VYNE
BlackRock Inc.
BLK
1,037,677
2.000%
1,037,677increase
(New Position)
View
2021-02-16
4:13 pm
Unchanged
13GVYNE THERAPEUTICS INC PAR$
VYNE
GREAT POINT PARTNERS LLC0
0.000%
0
(Unchanged)
View
2021-02-16
3:39 pm
Purchase
13GVYNE THERAPEUTICS INC PAR$
VYNE
PERCEPTIVE ADVISORS LLC27,095,819
14.300%
27,095,819increase
(New Position)
View
2021-02-16
3:28 pm
Purchase
13GVYNE THERAPEUTICS INC PAR$
VYNE
Point72 Asset Management L.P.26,040
0.100%
26,040increase
(New Position)
View
2021-02-16
2:41 pm
Sale
13GVYNE THERAPEUTICS INC PAR$
VYNE
FIRST MANHATTAN CO. LLC.21,319
0.010%
-2,146,694decrease
(-99.02%)
View
2021-02-11
1:56 pm
Sale
13GVYNE THERAPEUTICS INC PAR$
VYNE
JANUS HENDERSON GROUP PLC
JHG
0
0.000%
-1,281,133decrease
(Position Closed)
View
2021-02-02
3:13 pm
Purchase
13GVYNE THERAPEUTICS INC PAR$
VYNE
BlackRock Inc.
BLK
11,988,767
7.100%
11,988,767increase
(New Position)
View
2020-06-11
5:10 pm
Purchase
13GVYNE THERAPEUTICS INC PAR$
VYNE
PERCEPTIVE ADVISORS LLC22,876,410
14.000%
22,876,410increase
(New Position)
View
2020-06-11
5:09 pm
Sale
13GVYNE THERAPEUTICS INC PAR$
VYNE
Vivo Capital VIII LLC3,643,824
2.200%
-367,412decrease
(-9.16%)
View
2020-04-16
12:47 pm
Sale
13DVYNE THERAPEUTICS INC PAR$
VYNE
venBio Global Strategic Fund II L.P.0
0.000%
-1,461,552decrease
(Position Closed)
View
Goto 0, 1, Next